• +1 513 549 5911 (U.S.)
  • +44 203 318 2846 (U.K.)

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports

Antihypertensive Drugs

Global Antihypertensive Drugs Market Research Report Forecast to 2023


Antihypertensive Drugs Market Research Report: by Therapeutic Class (Calcium Channel Blockers, Beta-adrenergic Blockers, Renin Inhibitors, ACE Inhibitors, Vasodilators, Diuretics, ARBs, Others), by Type (Primary Hypertension, Secondary Hypertension), by Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-commerce Websites & Online Drug Stores, Others), and Region - Global Forecast till 2023
Market analysis 

Antihypertensive medications are prescribed by reputed clinicians for the management of hypertension or high blood pressure. The high pervasiveness of hypertension is the essential driver of the global antihypertensive medications market. Several awareness campaigns by several government and non-profit associations are probably going to work for the market. For example, the Pulmonary Hypertension Association (PHA) offers training programs and has a solid encouraging group of people which offers patients the right information about the treatment. The rising predominance of incessant illnesses is powering the interest of antihypertensive drugs or medications. What's more, the section of generics which has cut down patient expenses is anticipated to look good for the market over the forecast period (2018- 2023). The market is expected to grow at 2.67% CAGR during the forecast period. 

Market segmentation 

Based on its therapeutic classes, the global antihypertensive drugs market is segmented into beta-adrenergic blockers, calcium channel blockers, renin inhibitors, vasodilators, angiotensin II receptor blockers (ARBs), angiotensin-converting enzyme (ACE) inhibitors, diuretics, and others. On the basis of its type, the market is bifurcated into secondary and primary hypertension. Lastly, on the basis of its distribution channels, the market is bifurcated into hospital pharmacy, e-commerce websites and online drug stores, retail pharmacy, and others. 

Regional analysis 

Geographically, the global antihypertensive drugs market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa. 

Major players 

Merck KGaA (Germany), Johnson & Johnson Services, Inc. (U.S.), Bayer AG (Germany), Pfizer, Inc. (U.S.), and United Therapeutics Corporation (U.S.), Sanofi S.A. (France), Novartis AG (Switzerland), AstraZeneca (U.K.), Daiichi Sankyo Company, Ltd. (Japan), Boehringer Engelheim GmbH (Germany), Takeda Pharmaceutical Company (Japan), among others are some of the major players in the global antihypertensive drugs market.	
Table of Contents:

1	 Report Prologue
2	 Executive Summary
3	 Market Introduction
3.1	Definition
3.2	Scope of the Study
3.3	List of Assumptions
3.4	Market Structure
4	 Research Methodology
4.1	Research Process
4.2	Primary Research
4.3	Secondary Research
4.4	Market Size Estimation
4.5	Forecast Model
5	 Market Dynamics
5.1	Overview
5.2	Drivers
5.2.1	Rising prevalence of hypertension
5.2.2	Growing initiatives by private and government organizations
5.2.3	Rise in the prevalence rates of chronic diseases
5.2.4	Increasing penetration of generic versions of drugs
5.3	Restraints
5.3.1	Side-effects of treatment options
5.3.2	High cost of treatment
5.3.3	Loss of patents
5.3.4	Rise in non-pharmacological therapy
5.4	Opportunity
5.4.1	Emerging therapies in the treatment hypertension
6	 Market Factor Analysis
6.1	Value chain analysis
6.1.1	R&D and Designing
6.1.2	Manufacturing
6.1.3	Distribution & Sales
6.1.4	Post Sales Review
6.2	Porter’s Five Forces Model
6.2.1	Bargaining Power of Suppliers
6.2.1	Bargaining Power of Buyers
6.2.2	Threat of New Entrants
6.2.3	Threat of Substitutes
6.2.4	Intense Rivalry
6.3	Investment Opportunities
6.4	Pricing Analysis
7	 Global Antihypertensive Drugs Market, by Therapeutic Class
7.1	Overview
7.2	Diuretics
7.3	ACE Inhibitors
7.4	ARBs
7.5	Calcium Channel Blockers
7.6	Beta-Adrenergic Blockers
7.7	Renin Inhibitors
7.8	Vasodilators
7.9	Others
8	 Global Antihypertensive Drugs Market, by Type
8.1	Overview
8.2	Primary Hypertension
8.3	Secondary Hypertension
9	 Global Antihypertensive Drugs Market, by Distribution Channel
9.1	Overview
9.2	Retail Pharmacy
9.3	Hospital Pharmacy
9.4	E-commerce Websites & Online Drug Stores
9.5	Others
10	 Global Antihypertensive Drugs Market, by Region
10.1	Overview
10.2	Americas
10.2.1	North America
10.2.1.1	US
10.2.1.2	Canada
10.2.2	Latin America
10.3	Europe
10.3.1	Western Europe
10.3.1.1	Germany
10.3.1.2	France
10.3.1.3	UK
10.3.1.4	Italy
10.3.1.5	Spain
10.3.1.6	Rest of Western Europe
10.3.2	Eastern Europe
10.4	Asia-Pacific
10.4.1	Japan
10.4.2	China
10.4.3	India
10.4.4	Australia
10.4.5	South Korea
10.4.6	Rest of Asia-Pacific
10.5	Middle East & Africa
10.5.1	Middle East
10.5.2	Africa
11	 Competitive Landscape
11.1	Overview
11.2	Company Share Analysis
12	 Company Profile
12.1	Sanofi S. A.
12.1.1	Company Overview
12.1.2	Financial Overview
12.1.3	Products Offered
12.1.4	SWOT Analysis
12.1.5	Key Developments
12.1.6	Key strategy
12.2	Novartis AG
12.2.1	Company Overview
12.2.2	Financial Overview
12.2.3	Products Offered
12.2.4	SWOT Analysis
12.2.5	Key Developments
12.2.6	Key strategy
12.3	AstraZeneca
12.3.1	Company Overview
12.3.2	Financial Overview
12.3.3	Products Offered
12.3.4	SWOT Analysis
12.3.5	Key Developments
12.3.6	Key strategy
12.4	Daiichi Sankyo Company, Ltd
12.4.1	Company Overview
12.4.2	Financial Overview
12.4.3	Products Offered
12.4.4	SWOT Analysis
12.4.5	Key Developments
12.4.6	Key Strategy
12.5	Boehringer Ingelheim GmbH
12.5.1	Company Overview
12.5.2	Financial Overview
12.5.3	Products Offered
12.5.4	SWOT Analysis
12.5.5	Key Developments
12.5.6	Key Strategy
12.6	Takeda Pharmaceutical Company Ltd
12.6.1	Company Overview
12.6.2	Financial Overview
12.6.3	Products Offered
12.6.4	SWOT Analysis
12.6.5	Key Developments
12.6.6	Key Strategy
12.7	Merck KGaA
12.7.1	Company Overview
12.7.2	Financial Overview
12.7.3	Products Offered
12.7.4	SWOT Analysis
12.7.5	Key Developments
12.7.6	Key Strategy
12.8	Johnson & Johnson Services, Inc.
12.8.1	Company Overview
12.8.2	Financial Overview
12.8.3	Products Offered
12.8.4	SWOT Analysis
12.8.5	Key Developments
12.8.6	Key Strategy
12.9	Bayer AG
12.9.1	Company Overview
12.9.2	Financial Overview
12.9.3	Products Offered
12.9.4	SWOT Analysis
12.9.5	Key Developments
12.9.6	Key Strategy
12.1	Pfizer, Inc.
12.10.1	Company Overview
12.10.2	Financial Overview
12.10.3	Products Offered
12.10.4	SWOT Analysis
12.10.5	Key Developments
12.10.6	Key Strategy
12.11	United Therapeutics Corporation
12.11.1	Company Overview
12.11.2	Financial Overview
12.11.3	Products Offered
12.11.4	SWOT Analysis
12.11.5	Key Developments
12.11.6	Key Strategy
13	 Appendix
13.1	Discussion Blue Print

	List of Figures:

FIGURE 1	GLOBAL ANTIHYPERTENSIVE DRUGS MARKET: MARKET STRUCTURE
FIGURE 2	RESEARCH PROCESS OF MRFR
FIGURE 3	TOP-DOWN & BOTTOM-UP APPROACHES
FIGURE 4	MARKET DYNAMICS: ANALYSIS OF THE GLOBAL ANTIHYPERTENSIVE DRUGS MARKET
FIGURE 5	VALUE CHAIN: GLOBAL ANTIHYPERTENSIVE DRUGS MARKET
FIGURE 6	PORTER’S FIVE FORCES ANALYSIS: GLOBAL ANTIHYPERTENSIVE DRUGS MARKET
FIGURE 7	GLOBAL ANTIHYPERTENSIVE DRUGS MARKET, BY THERAPEUTIC CLASS, 2017 AND 2023 (USD MILLION)
FIGURE 8	GLOBAL ANTIHYPERTENSIVE DRUGS MARKET, BY TYPE, 2017 AND 2023 (USD MILLION)
FIGURE 9	GLOBAL ANTIHYPERTENSIVE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2017 AND 2023 (USD MILLION)
FIGURE 10	GLOBAL ANTIHYPERTENSIVE DRUGS MARKET, BY REGION, 2017 AND 2023 (USD MILLION)
FIGURE 11	AMERICAS: ANTIHYPERTENSIVE DRUGS MARKET, BY REGION, 2017 (%)
FIGURE 12	NORTH AMERICA: ANTIHYPERTENSIVE DRUGS MARKET, BY COUNTRY, 2017 (%)
FIGURE 13	EUROPE: ANTIHYPERTENSIVE DRUGS MARKET, BY REGION, 2017 (%)
FIGURE 14	WESTERN EUROPE: ANTIHYPERTENSIVE DRUGS MARKET, BY COUNTRY, 2017 (%)
FIGURE 15	ASIA-PACIFIC: ANTIHYPERTENSIVE DRUGS MARKET, BY COUNTRY, 2017 (%)
FIGURE 16	MIDDLE EAST & AFRICA: ANTIHYPERTENSIVE DRUGS MARKET, BY REGION, 2017 (%)
FIGURE 17	GLOBAL ANTIHYPERTENSIVE DRUGS MARKET: COMPANY SHARE ANALYSIS, 2017 (%)

Related Reports

Warm-Blood-Perfusion-System-Market

Global Warm Blood Perfusion System Market Research Report 2019-2023

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Warm Blood Perfusion System Report by Material, Application, and Geogr ...read more

Medicinal-Herbal-Extracts-Market

Global Medicinal Herbal Extracts Market Research Report 2019-2023

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Medicinal Herbal Extracts Report by Material, Application, and Geograp ...read more

Eye-Stent-Market

Global Eye Stent Market Research Report 2019-2023

iStents are very small tubes, approximately 1-millimeter-long, that are inserted into the eye. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big i ...read more

Minimally-Invasive-Neurosurgical-Device-Market

Global Minimally Invasive Neurosurgical Device Market Research Report 2019-2023

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Minimally Invasive Neurosurgical Device Report by Material, Applicatio ...read more

Electrodeionization-Market

Global Electrodeionization Market Research Report 2019-2023

Electrodeionization (EDI) is a water treatment technology that utilizes electricity, ion exchange membranes and resin to deionize water and separate dissolved ions (impurities) from water. In the cont ...read more

Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.

Cards For Payment
Trusted Badge SSL Certified Premium Quality

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

How To Reach Us

Reach out to our most senior Sales Professional- Jay Matthews
   +1 513 549 5911 (US)
          +44 203 318 2846 (UK)
   sales@reportsmonitor.com

Our Clients

Intel Samsung 3M BCG LEK Consulting McKinsey Thyssenkrupp Mogensen BASF IQVIA Hella Oracle Accenture Saint Gobain

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
--Marketing Manager at a pharma company in Belgium

Enquire Before Buying

Need to ask a quick question before buying? Please fill out this short form:

Our Features

Wide Network of Publishers

Wide Network of Publishers

Access to over 1M+ market research reports

Trusted by the Best

Trusted by the Best

50+ Clients in Fortune 500

Competitive Pricing

Competitive Pricing

Our regular promotional offers and discounts make us the most economic seller of market reports

Safe and Secure

Safe and Secure

Your payment details are protected by us.